NYU Langone Comprehensive Epilepsy Center

New York, New York 10016

3 studies enrolling now · 5 studies all time

What they study most

Drug Resistant Epilepsy, Epilepsies, Myoclonic, Epilepsy, Focal Epilepsy, Focal Onset Seizure, Focal Onset Seizures, Focal Seizure, Mesial Temporal Lobe Epilepsy, Refractory Focal Epilepsy, Seizure

Studies at this site

• Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy)) — Recruiting now
• A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures — Recruiting now
• Study Evaluating the Safety and Efficacy of RAP-219 in Adult Participants With Refractory Focal Epilepsy — Completed
• A Study of Lorcaserin as Adjunctive Treatment in Participants With Dravet Syndrome — Stopped early
• Extended Access Program With Lorcaserin For The Treatment of Dravet Syndrome and Other Refractory Epilepsies — Available (expanded access)